SITCO Pharma

Belkins
Saudi International Trading Company Ltd. (SITCO Pharma), is engaged in the Pharmaceutical distribution business in Saudi Arabia. The company, formed in 1990, is considered a leader in the field of pharmaceutical distribution in the Kingdom of Saudi Arabia. Representing several major multinational pharmaceutical companies, SITCO Pharma has quickly established the standards for excellence in its field. The management of SITCO Pharma includes 8 senior managers, each with an average of over 13 years of service and experience in Saudi Arabia. The rapid growth of SITCO Pharma is a testimony to the commitment and dedication of management and staff.

Related News

VIGILANZ LAUNCHES COVID QUICK START SOFTWARE THAT GIVES HOSPITALS CUSTOMIZABLE REAL-TIME ALERTS AND REPORTS TO MANAGE VIRAL OUTBREAKS

Prnewswire | May 21, 2020

news image

Hospitals can prepare for additional waves of COVID-19 and flu season in a matter of weeks, with no payments for six months. COVID Quick Start gives hospitals customizable real-time alerts and reports to manage viral outbreaks and exposures. Read More

PHARMACY MARKET

SPOTLITE360 INTRODUCES PHARMACEUTICAL INDUSTRY INITIATIVE FOR SUPPLY CHAIN TRACKING, TRACING, AND SUSTAINABILITY

Spotlite360 | July 07, 2021

news image

SPOTLITE360 TECHNOLOGIES, INC. is happy to announce that it has started an initiative to provide tailored supply chain tracing and tracking solutions for pharmaceutical companies, for which it is now in contract discussions with pharmaceutical firms. This effort coincides with an impending regulatory shift in the USD 1.3 trillion pharmaceutical industry1 that will require companies to comply with the Drug Supply Chain Security Act (“DSCSA”), which requires the deployment of electroni...

Read More

PHARMACY MARKET

PFIZER AND BIONTECH ANNOUNCE SUBMISSION OF INITIAL DATA TO U.S. FDA TO SUPPORT BOOSTER DOSE OF COVID-19 VACCINE

Pfizer | August 17, 2021

news image

Pfizer Inc. and BioNTech SE today announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies’ COVID-19 vaccine (BNT162b2) for future licensure. These data also will be submitted to the European Medicines Agency (EMA) and other regulatory authorities in the coming weeks. “The data we’ve seen to date suggest a third dose of our vaccine elicits antibody levels...

Read More

PHARMA TECH

FAREVA AND APIJECT SIGN A LICENSING AGREEMENT TO CREATE A FRANCE-BASED 500M UNIT ANNUAL CAPACITY FOR SINGLE-DOSE PREFILLED VACCINE INJECTIONS

ApiJect Systems Corp. | December 10, 2021

news image

Fareva and ApiJect Systems, Corp. announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect's innovative prefilled injector technology. Fareva intends to invest more than €50M for these three manufacturing lines, with support from the Government of France, through the "France Relance" industry ...

Read More
news image

VIGILANZ LAUNCHES COVID QUICK START SOFTWARE THAT GIVES HOSPITALS CUSTOMIZABLE REAL-TIME ALERTS AND REPORTS TO MANAGE VIRAL OUTBREAKS

Prnewswire | May 21, 2020

Hospitals can prepare for additional waves of COVID-19 and flu season in a matter of weeks, with no payments for six months. COVID Quick Start gives hospitals customizable real-time alerts and reports to manage viral outbreaks and exposures. Read More

news image

PHARMACY MARKET

SPOTLITE360 INTRODUCES PHARMACEUTICAL INDUSTRY INITIATIVE FOR SUPPLY CHAIN TRACKING, TRACING, AND SUSTAINABILITY

Spotlite360 | July 07, 2021

SPOTLITE360 TECHNOLOGIES, INC. is happy to announce that it has started an initiative to provide tailored supply chain tracing and tracking solutions for pharmaceutical companies, for which it is now in contract discussions with pharmaceutical firms. This effort coincides with an impending regulatory shift in the USD 1.3 trillion pharmaceutical industry1 that will require companies to comply with the Drug Supply Chain Security Act (“DSCSA”), which requires the deployment of electroni...

Read More
news image

PHARMACY MARKET

PFIZER AND BIONTECH ANNOUNCE SUBMISSION OF INITIAL DATA TO U.S. FDA TO SUPPORT BOOSTER DOSE OF COVID-19 VACCINE

Pfizer | August 17, 2021

Pfizer Inc. and BioNTech SE today announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies’ COVID-19 vaccine (BNT162b2) for future licensure. These data also will be submitted to the European Medicines Agency (EMA) and other regulatory authorities in the coming weeks. “The data we’ve seen to date suggest a third dose of our vaccine elicits antibody levels...

Read More
news image

PHARMA TECH

FAREVA AND APIJECT SIGN A LICENSING AGREEMENT TO CREATE A FRANCE-BASED 500M UNIT ANNUAL CAPACITY FOR SINGLE-DOSE PREFILLED VACCINE INJECTIONS

ApiJect Systems Corp. | December 10, 2021

Fareva and ApiJect Systems, Corp. announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect's innovative prefilled injector technology. Fareva intends to invest more than €50M for these three manufacturing lines, with support from the Government of France, through the "France Relance" industry ...

Read More